gyy-4137 and Cardiomyopathies

gyy-4137 has been researched along with Cardiomyopathies* in 1 studies

Other Studies

1 other study(ies) available for gyy-4137 and Cardiomyopathies

Article	Year
GYY4137 ameliorates sepsis-induced cardiomyopathy via NLRP3 pathway. Biochimica et biophysica acta. Molecular basis of disease, 2022, 12-01, Volume: 1868, Issue:12 Sepsis-induced cardiomyopathy (SICM) has a poor prognosis, with no effective therapeutic strategy currently. This study aimed to explore the mechanism underlying SICM and investigate the protective role of the hydrogen sulfide (H Topics: Animals; Cardiomyopathies; Cytokines; Hydrogen Sulfide; Inflammasomes; Lipopolysaccharides; Mice; Morpholines; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Organothiophosphorus Compounds; Reactive Oxygen Species; RNA; Sepsis	2022

Article

Year

GYY4137 ameliorates sepsis-induced cardiomyopathy via NLRP3 pathway.

Biochimica et biophysica acta. Molecular basis of disease, 2022, 12-01, Volume: 1868, Issue:12

Sepsis-induced cardiomyopathy (SICM) has a poor prognosis, with no effective therapeutic strategy currently. This study aimed to explore the mechanism underlying SICM and investigate the protective role of the hydrogen sulfide (H

Topics: Animals; Cardiomyopathies; Cytokines; Hydrogen Sulfide; Inflammasomes; Lipopolysaccharides; Mice; Morpholines; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Organothiophosphorus Compounds; Reactive Oxygen Species; RNA; Sepsis

2022